Chronic bronchitis. Managing the disease and related infections.
Chronic bronchitis is characterized by chronic, productive cough present on most days for at least three months of the year. Differential diagnosis must exclude an endobronchial obstructive lesion, asthma, nocturnal aspiration, bronchiectasis, cystic fibrosis, and immotile cilia syndrome. The most characteristic finding in patients with chronic bronchitis is hypertrophy of the mucous glands and goblet cells.
D000437:Alcoholism / Q000150:complications; D000658:Amoxicillin / Q000627:therapeutic use; D000667:Ampicillin / Q000627:therapeutic use; D000818:Animals; D001991:Bronchitis / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002908:Chronic Disease; D003937:Diagnosis, Differential; D004285:Dogs; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D009241:Ipratropium / Q000627:therapeutic use; D007710:Klebsiella Infections / Q000150:complications / Q000188:drug therapy; D009921:Metaproterenol / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000150:complications; D013420:Sulfamethoxazole / Q000627:therapeutic use; D013752:Tetracycline; D014295:Trimethoprim / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D001993:Bronchodilator Agents; D004338:Drug Combinations; D009921:Metaproterenol; D000667:Ampicillin; D000658:Amoxicillin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013752:Tetracycline; D009241:Ipratropium; D013420:Sulfamethoxazole